摘要特发性矮小（idiopathic short stature,ISS）是儿童矮小症中最常见的类型,因病因尚未完全阐明,目前治疗首选重组人生长激素,但疗效存在差异,成本过高是医患共同面对的问题,进一步明确其病因,寻找更好的治疗是儿科内分泌医生关注的焦点,本文对目前国内外关于特发性矮小的研究作一综述。
7Wit J M,Balen H V,Kamp G A, et al. Benefit of postponing normal puberty for improving final height[J]. Eur J Endocinol, 2004,151(S 1) :$41-$45.
8Pasquino A M, Pucarelli L, Roggini M, et al. Adult height in short normal girls treated with gonadotropin-releasing hor- mone analogs and growth hormone [J]. J Clin Endocrinol Metab,2000,85(2) ：619-622.
9Hero M, Norjavaara E, Dunkel L. Inhibition of estrogen bio- syn-thesis with a potent aromatase inhibitor increases predic- ted adult height in boys with idiopathic short stature: a ran- domized controlled trial[J]. J Clin Endocrinol Metab, 2005,90 (12) : 6396-6402.
10Wit J M,Clayton P E,Rogol A D,et al. Idiopathic short sta- ture: definition, epidemiology, and diagnostic evaluation[J]. Growth Horm IGF Res,2008,18(2) :89-110.
8Kant SG, Wit JM, Breuning MH. Genetic analysis of short stature. Horm Res, 2003,60 : 157-165.
9Rao E, Weiss B, Fukami M, et al. Pseudoautosomal deletions encompassing a novel homeobox gene cause growth failure in idiopathic short stature and Turner syndrome. Nat Genet, 1997,16:54-63.
10Shears D J, Vasssal H J, Goodman FR, et al. Mutation and deletion of the pseudoautosomal gene SHOX cause Leri-Weill dyschodrosteosis. Nat Genet, 1998,19:70-73.
